In cells lining the airway, high levels of certain proteins have long been linked with the overproduction of mucus characteristic of diseases like asthma and COPD. New research from the School of Medicine provides clues to potentially counteract inappropriate mucus production.
A Washington University drug discovery program, led by Michael Holtzman, MD, has received three grants totaling more than $5 million to develop new medical therapeutics for respiratory diseases. The target illnesses range from the common cold to life-threatening lung disease.
New research at the School of Medicine points to a common species of bacteria as an important contributor to bacterial vaginosis, a condition linked to preterm birth and increased risk of sexually transmitted diseases. Pictured is a single cell of the bacteria that may be causing the problem, Gardnerella vaginalis.
Washington University in St. Louis has awarded five Bear Cub fund grants totaling $190,000 to support innovative research that has shown commercial potential. Jerry Morrissey (right), PhD, received one of the grants to develop rapid tests for the early development of kidney cancer.